Ken Griffin Abcam PLC Transaction History

Citadel Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$21.54 - $24.41 $43.6 Million - $49.4 Million	-2,025,136 Reduced 29.4%	4,862,089 $110 Million
Q2 2023 Aug 14, 2023	BUY	$12.62 - $24.47 $85.6 Million - $166 Million	6,784,907 Added 6631.2%	6,887,225 $169 Million
Q1 2023 May 15, 2023	SELL	$12.98 - $17.1 $1.35 Million - $1.77 Million	-103,793 Reduced 50.36%	102,318 $1.38 Million
Q4 2022 Feb 14, 2023	SELL	$13.92 - $17.0 $715,334 - $873,613	-51,389 Reduced 19.96%	206,111 $3.21 Million
Q3 2022 Nov 14, 2022	BUY	$13.36 - $16.75 $1.69 Million - $2.12 Million	126,803 Added 97.02%	257,500 $3.86 Million
Q2 2022 Aug 15, 2022	BUY	$12.69 - $19.25 $281,489 - $427,003	22,182 Added 20.44%	130,697 $1.89 Million
Q1 2022 May 16, 2022	BUY	$15.5 - $23.89 $317,951 - $490,055	20,513 Added 23.31%	108,515 $1.99 Million
Q4 2021 Feb 14, 2022	SELL	$20.04 - $23.84 $814,605 - $969,072	-40,649 Reduced 31.6%	88,002 $2.07 Million
Q3 2021 Nov 15, 2021	SELL	$17.38 - $21.54 $24,175 - $29,962	-1,391 Reduced 1.07%	128,651 $2.61 Million
Q2 2021 Aug 16, 2021	BUY	$18.47 - $22.11 $1.61 Million - $1.93 Million	87,234 Added 203.78%	130,042 $2.48 Million
Q1 2021 May 17, 2021	BUY	$19.22 - $24.3 $196,601 - $248,564	10,229 Added 31.4%	42,808 $822,000
Q4 2020 Feb 16, 2021	BUY	$18.2 - $22.45 $592,937 - $731,398	32,579 New	32,579 $702,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.